Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.

Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.

Show other versions (1)

Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has dominated travel medicine strategy since the advent of chloroquine in 1946. The lethal threat of falciparum malaria versus the perceived benign consequence of vivax malaria underpins this strategic posture....

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Baird, J
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2013

Eitemau Tebyg

Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria
gan: Baird, J
Cyhoeddwyd: (2013)

Management of Plasmodium vivax risk and illness in travelers
gan: Baird, J
Cyhoeddwyd: (2017)

Management of Plasmodium vivax risk and illness in travelers
gan: J. Kevin Baird
Cyhoeddwyd: (2017-03-01)

Neglect of Plasmodium vivax malaria.
gan: Baird, J
Cyhoeddwyd: (2007)

“Lively” invasive Plasmodium vivax causes severe and complicated malaria
gan: Baird, J
Cyhoeddwyd: (2019)

Rational malaria chemoprophylaxis - the position of primaquine
gan: Baird, J
Cyhoeddwyd: (2017)

Diagnosis and treatment of Plasmodium vivax malaria.
gan: Baird, K, et al.
Cyhoeddwyd: (2012)

Diagnosis and treatment of Plasmodium vivax malaria
gan: Baird, J, et al.
Cyhoeddwyd: (2016)

THE HUMAN LIVER AS A RESERVOIR OF INFECTION: THE EPIDEMIOLOGY AND CONTROL OF MALARIA CAUSED BY PLASMODIUM VIVAX
gan: Baird, J
Cyhoeddwyd: (2013)

Challenges in the Control and Elimination of Plasmodium vivax Malaria
gan: Asih, P, et al.
Cyhoeddwyd: (2018)

Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria.
gan: Valecha, N, et al.
Cyhoeddwyd: (2009)

Unexpectedly long incubation period of <it>Plasmodium vivax </it>malaria, in the absence of chemoprophylaxis, in patients diagnosed outside the transmission area in Brazil
gan: da Silveira Bressan Clarisse, et al.
Cyhoeddwyd: (2011-05-01)

Evidence and implications of mortality associated with acute Plasmodium vivax malaria.
gan: Baird, J
Cyhoeddwyd: (2013)

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
gan: Baird, J
Cyhoeddwyd: (2018)

Chemoprophylaxis and the epidemiological characteristics of re-emergent P. vivax malaria in the Republic of Korea
gan: Changsoo Kim, et al.
Cyhoeddwyd: (2006-10-01)

The global burden of Plasmodium vivax malaria is obscure and insidious
gan: Battle, KE, et al.
Cyhoeddwyd: (2021)

Serious and fatal illness associated with falciparum and vivax malaria among patients admitted to hospital at West Sumba in eastern Indonesia.
gan: Nurleila, S, et al.
Cyhoeddwyd: (2012)

Plasmodium Vivax Malaria: Usual Illness with Dysregulated Immune Profile
gan: Richa Gupta, et al.
Cyhoeddwyd: (2020-09-01)

Plasmodium vivax Malaria
gan: Dhanpat K. Kochar, et al.
Cyhoeddwyd: (2005-01-01)

Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
gan: Taylor, A, et al.
Cyhoeddwyd: (2019)

Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
gan: Aimee R. Taylor, et al.
Cyhoeddwyd: (2019-12-01)

Plasmodium vivax malaria endemicity in Indonesia in 2010
gan: Elyazar, I, et al.
Cyhoeddwyd: (2012)

Attacking Plasmodium vivax
gan: Baird, J
Cyhoeddwyd: (2016)

Malaria caused by Plasmodium vivax: recurrent, difficult to treat, disabling, and threatening to life--the infectious bite preempts these hazards.
gan: Kevin Baird, J
Cyhoeddwyd: (2013)

Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
gan: Wells, T, et al.
Cyhoeddwyd: (2010)

The anaemia of <it>Plasmodium vivax</it> malaria
gan: Douglas Nicholas M, et al.
Cyhoeddwyd: (2012-04-01)

Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
gan: Maguire, J, et al.
Cyhoeddwyd: (2006)

The burden of Plasmodium vivax malaria
gan: Battle, K
Cyhoeddwyd: (2015)

The anaemia of Plasmodium vivax malaria.
gan: Douglas, N, et al.
Cyhoeddwyd: (2012)

A fatal respiratory complication of malaria caused by Plasmodium vivax
gan: Angie R. López, et al.
Cyhoeddwyd: (2023-10-01)

Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization
gan: Wiebke Nahrendorf, et al.
Cyhoeddwyd: (2015-02-01)

Acquired immunity in a holoendemic setting of Plasmodium falciparum and p. Vivax malaria.
gan: Baird, J, et al.
Cyhoeddwyd: (2007)

Chloroquine resistance in Plasmodium vivax.
gan: Baird, J
Cyhoeddwyd: (2004)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
gan: Baird, JK
Cyhoeddwyd: (2021)

The prevention and treatment of Plasmodium vivax malaria.
gan: Cindy S Chu, et al.
Cyhoeddwyd: (2021-04-01)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
gan: Twohig, K, et al.
Cyhoeddwyd: (2019)

Effects of Plasmodium vivax malaria in pregnancy.
gan: Nosten, F, et al.
Cyhoeddwyd: (1999)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
gan: Krudsood, S, et al.
Cyhoeddwyd: (2008)

Chemoprophylaxis and Malaria Death Rates
gan: Gérard Krause, et al.
Cyhoeddwyd: (2006-03-01)

The epidemiology of Plasmodium vivax. Preface.
gan: Hay, S, et al.
Cyhoeddwyd: (2013)